News Release

IOF Olof Johnell Science Award presented to Professor Serge Ferrari

The award recognizes an individual who has made outstanding global contributions to the field of osteoporosis in a scientific or policy implementation area

Grant and Award Announcement

International Osteoporosis Foundation

Malaga, Spain, April 17, 2016

Professor Serge Ferrari, Associate Professor of Medicine and Senior Consultant in Metabolic bone diseases at the Geneva University Hospital has been named winner of the International Osteoporosis Foundation's 2016 Olof Johnell Science Award, presented during the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.

The Olof Johnell Science Award, named in honour of the late Professor Olof Johnell, is awarded annually to an individual who has contributed to the field of osteoporosis in a scientific or policy implementation area, worldwide.

Professor Bess Dawson-Hughes, IOF Board member and Professor of Medicine at Tufts University presented the Award in Malaga. She stated, "Serge Ferrari is a clear thought leader within the field of bone health, known for his work in the areas of bone growth, genetics of osteoporosis and bone remodeling. The focus of his outstanding research is on the translation of new findings on the biological and pharmacological mechanisms of action on bone into improved patient care in osteoporosis and metabolic bone disorders."

Serge Ferrari is Full Professor of Medicine at the Faculty of Medicine, University of Geneva, Switzerland. He is also Head of the Clinical Service and Research Laboratory of Bone Diseases at the Department of Internal Medicine Specialties, Geneva University Hospital. Professor Ferrari obtained his medical degree from the Faculty of Medicine, University of Geneva in 1989. He trained in internal medicine and pathophysiology at Geneva University Hospital, and subsequently as a research and clinical fellow in bone diseases and endocrinology at Beth Israel Deaconess Hospital in Boston, USA. Professor Ferrari was the nominated Instructor in Medicine at Harvard Medical School, Boston, in 2000 and was also the recipient of a Professorship grant from the Swiss National Science Foundation in 2001. He is Vice-chair of the Committee of Scientific Advisors of the International Osteoporosis Foundation, past President of the Swiss Bone and Mineral Society, and current Vice-president of the Swiss Association against Osteoporosis. He is Editor-in-Chief of BoneKEy Reports (Nature publishing group) from the International Bone and Mineral Society, and a member of the editorial board of several scientific journals including Osteoporosis International and Bone. Professor Ferrari has published over 200 articles and book chapters in the field of osteoporosis and bone and mineral metabolism.


About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2016) :

Held jointly by IOF and ESCEO, the Congress is taking place in Malaga, Spain from April 14-17,2016. It is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. The next Congress will be held in Florence, Italy from March 23-26, 2017. For complete information visit #OsteoCongress

About IOF :

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 234 patient, medical and research societies in 99 locations, work together to make bone, joint and muscle health a worldwide heath care priority. / /

About ESCEO :

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.